Ponazuril 150 Mg/G Oral Paste

62 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

970.0%

Death Rate

Active Ingredients

Ponazuril 150 Mg/G Oral Paste

Administration Routes

OralUnknown

Species Affected

Horse 27

Unknown 18

Dog 10

Cat 4

Goat 1

Human 1

Other Rodents 1

Most Affected Breeds

Unknown 20

Quarter Horse 11

Thoroughbred 4

Horse (unknown) 3

Domestic Shorthair 3

Irish Cob (Tinker) 2

Hanovarian 2

Tennessee Walking Horse 1

Warmblood (unspecified) 1

Goat (unknown) 1

Most Reported Reactions

Product Defect, General 13

Lethargy (see also Central nervous system depression in 'Neurological') 7

Lack of efficacy - NOS 7

Recumbency 5

Lack of efficacy (protozoa) - NOS 5

Fever 5

Death 5

Ataxia 4

Hives (see also 'Skin') 3

Increased sweating 3

Not eating 3

Blistering (see also Application site SOC) 2

Outcome Breakdown

Outcome Unknown

27 (61.4%)

Ongoing

6 (13.6%)

Died

5 (11.4%)

Recovered/Normal

5 (11.4%)

Euthanized

1 (2.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.